Annual Cash & Cash Equivalents
$1.12 B
+$102.00 M+10.01%
December 1, 2024
Summary
- As of February 10, 2025, XYL annual cash & cash equivalents is $1.12 billion, with the most recent change of +$102.00 million (+10.01%) on December 1, 2024.
- During the last 3 years, XYL annual cash & cash equivalents has fallen by -$228.00 million (-16.90%).
- XYL annual cash & cash equivalents is now -40.21% below its all-time high of $1.88 billion, reached on December 31, 2020.
Performance
XYL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.12 B
+$132.00 M+13.35%
December 1, 2024
Summary
- As of February 10, 2025, XYL quarterly cash and cash equivalents is $1.12 billion, with the most recent change of +$132.00 million (+13.35%) on December 1, 2024.
- Over the past year, XYL quarterly cash and cash equivalents has increased by +$102.00 million (+10.01%).
- XYL quarterly cash and cash equivalents is now -40.21% below its all-time high of $1.88 billion, reached on December 31, 2020.
Performance
XYL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
XYL Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.0% | +10.0% |
| 3 y3 years | -16.9% | +59.0% |
| 5 y5 years | +54.8% | +59.0% |
XYL Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -16.9% | +18.8% | -16.9% | +59.0% |
| 5 y | 5-year | -40.2% | +54.8% | -40.2% | +59.0% |
| alltime | all time | -40.2% | +1284.0% | -40.2% | +755.7% |
Xylem Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $1.12 B(+10.0%) | $1.12 B(+13.3%) |
| Sep 2024 | - | $989.00 M(+21.3%) |
| Jun 2024 | - | $815.00 M(-13.9%) |
| Mar 2024 | - | $947.00 M(-7.1%) |
| Dec 2023 | $1.02 B(+7.9%) | $1.02 B(+44.5%) |
| Sep 2023 | - | $705.00 M(-0.4%) |
| Jun 2023 | - | $708.00 M(-15.4%) |
| Mar 2023 | - | $837.00 M(-11.3%) |
| Dec 2022 | $944.00 M(-30.0%) | $944.00 M(-20.4%) |
| Sep 2022 | - | $1.19 B(+6.6%) |
| Jun 2022 | - | $1.11 B(-0.4%) |
| Mar 2022 | - | $1.12 B(-17.2%) |
| Dec 2021 | $1.35 B(-28.1%) | $1.35 B(+7.5%) |
| Sep 2021 | - | $1.25 B(-31.8%) |
| Jun 2021 | - | $1.84 B(+9.0%) |
| Mar 2021 | - | $1.69 B(-10.0%) |
| Dec 2020 | $1.88 B(+159.0%) | $1.88 B(+33.7%) |
| Sep 2020 | - | $1.40 B(-11.1%) |
| Jun 2020 | - | $1.58 B(+113.4%) |
| Mar 2020 | - | $739.00 M(+2.1%) |
| Dec 2019 | $724.00 M(+144.6%) | $724.00 M(+59.8%) |
| Sep 2019 | - | $453.00 M(+18.3%) |
| Jun 2019 | - | $383.00 M(+39.3%) |
| Mar 2019 | - | $275.00 M(-7.1%) |
| Dec 2018 | $296.00 M(-28.5%) | $296.00 M(-26.7%) |
| Sep 2018 | - | $404.00 M(+25.9%) |
| Jun 2018 | - | $321.00 M(+8.1%) |
| Mar 2018 | - | $297.00 M(-28.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $414.00 M(+34.4%) | $414.00 M(+46.3%) |
| Sep 2017 | - | $283.00 M(-1.7%) |
| Jun 2017 | - | $288.00 M(+0.3%) |
| Mar 2017 | - | $287.00 M(-6.8%) |
| Dec 2016 | $308.00 M(-54.7%) | $308.00 M(-53.3%) |
| Sep 2016 | - | $659.00 M(+12.5%) |
| Jun 2016 | - | $586.00 M(-50.9%) |
| Mar 2016 | - | $1.19 B(+75.4%) |
| Dec 2015 | $680.00 M(+2.6%) | $680.00 M(+11.3%) |
| Sep 2015 | - | $611.00 M(+1.8%) |
| Jun 2015 | - | $600.00 M(+8.3%) |
| Mar 2015 | - | $554.00 M(-16.4%) |
| Dec 2014 | $663.00 M(+24.4%) | $663.00 M(+25.3%) |
| Sep 2014 | - | $529.00 M(+17.6%) |
| Jun 2014 | - | $450.00 M(-3.4%) |
| Mar 2014 | - | $466.00 M(-12.6%) |
| Dec 2013 | $533.00 M(+5.8%) | $533.00 M(+35.3%) |
| Sep 2013 | - | $394.00 M(+9.4%) |
| Jun 2013 | - | $360.00 M(-4.0%) |
| Mar 2013 | - | $375.00 M(-25.6%) |
| Dec 2012 | $504.00 M(+58.5%) | $504.00 M(+18.9%) |
| Sep 2012 | - | $424.00 M(+18.4%) |
| Jun 2012 | - | $358.00 M(+3.2%) |
| Mar 2012 | - | $347.00 M(+9.1%) |
| Dec 2011 | $318.00 M(+142.7%) | $318.00 M(+72.8%) |
| Sep 2011 | - | $184.00 M(+19.5%) |
| Mar 2011 | - | $154.00 M(+17.6%) |
| Dec 2010 | $131.00 M(+61.7%) | $131.00 M |
| Dec 2009 | $81.00 M | - |
FAQ
- What is Xylem annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Xylem?
- What is Xylem annual cash & cash equivalents year-on-year change?
- What is Xylem quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Xylem?
- What is Xylem quarterly cash and cash equivalents year-on-year change?
What is Xylem annual cash & cash equivalents?
The current annual cash & cash equivalents of XYL is $1.12 B
What is the all time high annual cash & cash equivalents for Xylem?
Xylem all-time high annual cash & cash equivalents is $1.88 B
What is Xylem annual cash & cash equivalents year-on-year change?
Over the past year, XYL annual cash & cash equivalents has changed by +$102.00 M (+10.01%)
What is Xylem quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of XYL is $1.12 B
What is the all time high quarterly cash and cash equivalents for Xylem?
Xylem all-time high quarterly cash and cash equivalents is $1.88 B
What is Xylem quarterly cash and cash equivalents year-on-year change?
Over the past year, XYL quarterly cash and cash equivalents has changed by +$102.00 M (+10.01%)